Abaloparatide approved

'Bone Up' di Dr Richie Abel (PhD) and Prof David Armstrong (MD)

Note sull'episodio

The lads talked to each other about the exciting news that the National Institute for Health and Care Excellence (Nice) announced it had approved a new drug, Abaloparatide, for use by the health service. It will be available for use on the NHS in England within three months.

Parole chiave
osteoporosisfracture riskboneimminent fracturefracture liason servicefracturehip fracturefragility fractures